ImprimisRx NJ
ImprimisRx NJ appears in FDA public data with 3 recalls, 0 510(k) clearances, 6 FDA inspections, and 2 compliance actions on record. Its most recent recall (D-0060-2023, Class II) was initiated on November 9, 2022.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 6
- Compliance Actions
- 2
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0060-2023 | Class II | Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, | November 9, 2022 |
| D-1578-2019 | Class II | Timolol-Latanoprost P-F (0.5/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRX | July 17, 2019 |
| D-1579-2019 | Class II | Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx | July 17, 2019 |